IP Library Granted Patent US 7,696,231
Granted Patent B2
US 7,696,231 · App. 10/493,066 · Granted Apr 13, 2010

Oxindole hydrazide modulators of protein tyrosine phosphatases (PTPs)

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,696,231
App. No.
10/493,066
Granted
Apr 13, 2010
Kind
B2
Abstract

The present invention is related to the use of oxindole hydrazide derivatives of formula (I) for the treatment and/or prevention of metabolic disorders mediated by insulin resistance or hyperglycemia, comprising diabetes type I and/or II, inadequate glucose tolerance, insulin resistance, hyperlipidemia, hypertriglyceridemia, hypercholesterolemia, obesity, polycystic ovary syndrome (PCOS). In particular, the present invention is related to the use of oxindole hydrazide derivatives of formula (I) to modulate, notably to inhibit the activity of PTPs, in particular of PTP1B, TC-PTP, SHP and GLEPP-1. The present invention is furthermore related to novel oxindole hydrazide derivatives and method of preparation thereof.(I).

Claims (152)

1. An oxindole hydrazide of formula (II)

wherein A is O or a bond;

B is independently optionally substituted phenyl, naphthyl, phenantrenyl, pyrrolyl, furyl, thienyl, imidazolyl, oxazolyl, isoxazolyl, thiazolyl, isothiazolyl, pyrazolyl, [1,3]thiazolo [3,2-b][1,2,4]triazolyl, carbazolyl, 1,2,3-triazolyl, 1,2,4-triazolyl, 1,2,3-oxadiazolyl, benzo (2, 1, 3) oxadiazolyl, benzo (1,2,5) oxadiazolyl, 1,2,4-oxadiazolyl, 1,2, 5-oxadiazolyl, 1,3,4-oxadiazolyl, tetrazolyl, 1,3,4-triazinyl, 1,2,3-triazinyl, benzofuryl, [2,3- dihydro]benzofuryl, isobenzofuryi, benzothienyl, benzotriazolyl, isobenzothienyl, indolyl, isoindolyl, 3H-indolyl, benzimidazolyl, benzothiazolyl, benzoxazolyl, pyridazinyl, pyrirnidyl, quinolizinyl, quinazolinyl, pthalazinyl, quinoxalinyl, cinnolinyl, napthyridinyl, quinolyl, isoquinolyl, tetrazolyl, 5,6,7,8-tetrahydroquinolyl, 5,6,7,8-tetrahydroisoquinolyl, purinyl, pteridinyl, carbazolyl, xanthenyl, benzoquinolyl, cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, cycloheptyl, cyclooctyl, oxolanyl, pyrolidinyl, pyrazolidinyl, piperidinyl, piperazinyl, pyridyl, imidazolidinyl, 1,2,4-oxadiazolidinyl, 1,2,5-oxadiazolidinyl, 1,3,4-oxadiazolidinyl, isoxazolidinyl or morpholinyl;

R 8 is selected in the group consisting of H, halogen, cyano, (C 1 -C 6 )alkyl, aryl, heteroaryl, —SO—R 9 , —SO 2 —R 9 ,(C 1 -C 6 )alkyl-SO 2 —R 9 , —NO 2 , —N(R 9 ) 2 , (C 1 -C 6 )-alkyl-O—R 9 , —SR 9 , —SO 2 —R 9 , —(C═O)O—R 9 , —(C═O)—R 9 , —(C═O)N(R 9 ) 2 , —(C═O)NH—R 9 , —(C═O)NR 9 —N(R 9 ) 2 , —NR 9 —(C═O)—N(R 9 ) 2 , —NR 9 —(SO 2 —R 9 ), —NH—(C═O)—R 9 , (C 1 -C 6 )-alkyl-NH—(C═O)—R 9 , —NR 9 —(C═O)—R 9

wherein R 9 is selected from the group consisting of H, C 3 -C 8 cycloalkyl, 3-8 membered heterocycloalkyl which may contain 1-2 further heteroatoms selected from O, N or S, (C 1 -C 6 )-alkyl-heterocycloalkyl wherein said heterocycloalkyl may contain 1-2further heteroatoms selected from O, N or S, aryl, (C 1 -C 6 )-alkyl-aryl, (C 1 -C 6 )-alkoxy-aryl, heteroaryl, (C 1 -C 6 )-alkyl-heteroaryl or (C 1 -C 6 )-alkoxy-heteroaryl, (C 1 -C 6 )-alkyl, (C 1 -C 6 )-alkyl-COOR 10 wherein R 10 is H or (C 1 -C 6 )alkyl or —NH 2

m′ is 0 or 1;

p is an integer from 1 to 3;

with the proviso that the following compounds are excluded:

2. An oxindole hydrazide according to claim 1 , wherein B is a phenyl group and m′ is 0.

3. An oxindole hydrazide according to claim 2 wherein m′ is 0, p is 0 or 1, A is a bond or O, B is a phenyl group and R 8 is selected in the group consisting of —O 2 , —CO 2 —R 9 and —NH—(C═O)—R 9 wherein R 9 is selected from the group consisting of H, C 3 -C 8 cycloalkyl, 3-8 membered heterocycloalkyl which may contain 1-2 further heteroatoms selected from O , N or S, (C 1 -C 6 )-alkyl-heterocycloalkyl wherein said heterocycloalkyl may contain 1-2 further heteroatoms selected from O, N or S, aryl, (C 1 -C 6 )-alkyl-aryl, (C 1 -C 6 )-alkoxy-aryl, heteroaryl, (C 1 -C 6 )-alkyl-heteroaryl or (C 1 -C 6 )-alkoxy-heteroaryl, (C 1 -C 6 )-alkyl, (C 1 -C 6 )-alkyl-COOR 10 wherein R 10 is H or (C 1 -C 6 )alkyl or —NH 2 .

4. An oxindole hydrazide according to claim 1 , wherein said oxindole hydrazide is selected from the group consisting of:

N-(4-{[2-(5-Iodo-2-oxo-1,2-dihydro-3H-indol-3-ylidene)hydrazino]carbonyl}phenyl) -3-phenylpropanamide;

3,5-Dichloro-N′-(5-iodo-2-oxo-1,2-dihydro-3H-indol-3-ylidene)benzohydrazide;

N′-(5-Iodo-2-oxo-1,2-dihydro-3H-indol-3-ylidene)benzohydrazide;

N′-(5-Iodo-2-oxo-1,2-dihydro-3H-indol-3-ylidene)-4-methylbenzohydrazide;

4-Hydroxy-N′-(5-iodo-2-oxo-1,2-dihydro-3H-indol-3-ylidene)benzohydrazide;

3-Hydroxy-N′-(5-iodo-2-oxo-1,2-dihydro-3H-indol-3-ylidene)benzohydrazide;

N′-(5-Iodo-2-oxo-1,2-dihydro-3H-indol-3-ylidene)-2-nitrobenzohydrazide;

N′-(5-Iodo-2-oxo-1,2-dihydro-3H-indol-3-ylidene)-4-phenoxybenzohydrazide;

N′-(5-Iodo-2-oxo-1,2-dihydro-3H-indol-3-ylidene)-4-(trifluoromethyl) benzohydrazide;

4-tert-Butyl-N′-(5-Iodo-2-oxo-1,2-dihydro-3H-indol-3-ylidene)benzohydrazide;

N′-(5-Iodo-2-oxo-1,2-dihydro-3H-indol-3-ylidene)[1,1′-biphenyl]-4-carbohydrazide;

4-Bromo-N′-(5-iodo-2-oxo-1,2-dihydro-3H-indol-3-ylidene)benzohydrazide;

N′-(5-Iodo-2-oxo-1,2-dihydro-3H-indol-3-ylidene)-3-nitrobenzohydrazide;

N′-(5-Iodo-2-oxo-1,2-dihydro-3H-indol-3-ylidene)-4-methoxybenzohydrazide;

N′-(5-Iodo-2-oxo-1,2-dihydro-3H-indol-3-ylidene)-3-methoxybenzohydrazide;

4-Amino-N′-(5-iodo-2-oxo-1,2-dihydro-3H-indol-3-ylidene)benzohydrazide;

4-(Dimethylamino)-N′-(5-iodo-2-oxo-1,2-dihydro-3H-indol-3-lidene)benzohydrazide;

N′-(5-Iodo-2-oxo-1,2-dihydro-3H-indol-3-ylidene)-2-(4-nitrophenoxy) acetohydrazide;

N′-(5-Iodo-2-oxo-1,2-dihydro-3H-indol-3-ylidene)-4-(trifluoromethoxy) benzohydrazide;

N′-(5-Iodo-2-oxo-1,2-dihydro-3H-indol-3-ylidene)-2,1,3-benzoxadiazole-5-carbohydrazide;

N′-(5-Iodo-2-oxo-1,2-dihydro-3H-indol-3-ylidene)-((5-nitro)-2-furohydrazide);

Methyl 4-{[2-(5-iodo-2-oxo-1,2-dihydro-3H-indol-3-ylidene)hydrazino]carbonyl}benzoate;

Methyl 4-{2-[2-(5-iodo-2-oxo-1,2-dihydro-3H-indol-3-ylidene)hydrazino]-2-oxoethoxy}benzoate;

4-{[2-(5-Iodo-2-oxo-1,2-dihydro-3H-indol-3-ylidene)hydrazino]carbonyl}benzoic acid;

4-Iodo-N′-(5-Iodo-2-oxo-1,2-dihydro-3H-indol-3-ylidene)benzohydrazide;

N′-(5-Iodo-2-oxo-1,2-dihydro-3H-indol-3-ylidene)-3-phenoxybenzohydrazide;

N′-(5-Iodo-2-oxo-1,2-dihydro-3H-indol-3-ylidene)-2-(4-iodophenoxy)acetohydrazide;

N′-(5-Iodo-2-oxo-1,2-dihydro-3H-indol-3-ylidene)-2-[(4-methylphenyl) sulfonyl]acetohydrazide;

2-{[(2-Furylmethyl)sulfonyl]methyl}-N′-(5-iodo-2-oxo-1,2-dihydro-3H-indol-3-ylidene) -1,3-thiazole-4-carbohydrazide;

2-Hydroxy-N′-(-5-iodo-2-oxo-1,2-dihydro-3H-indol-3-ylidene)benzohydrazide;

N-(2-Furylmethyl)-N′-{2-[2-(5-iodo-2-oxo-1,2-dihydro-3H-indol-3-ylidene) hydrazino]-2-oxoethyl}urea;

N′-(5-Iodo-2-oxo-1,2-dihydro-3H-indol-3-ylidene)-4-(methylsulfanyl) benzohydrazide;

Methyl 6-{[2-(5-iodo-2-oxo-1,2-dihydro-3H-indol-3-ylidene) hydrazino]carbonyl}nicotinate;

Benzyl 4-{2-[2-(5-iodo-2-oxo-1,2-dihydro-3H-indol-3-ylidene)hydrazine]-2-oxoethoxy}benzoate;

N-(4-{[2-(5-Iodo-2-oxo-1,2-dihydro-3H-indol-3-ylidene)hydrazino]carbonyl}phenyl)-2-furamide;

N-(4-{[2-(5-Iodo-2-oxo-1,2-dihydro-3H-indol-3-ylidene)hydrazino]carbonyl}phenyl)hexanamide;

4-Cyano-N-(4-{[2-(5-iodo-2-oxo-1,2-dihydro-3H-indol-3-ylidene)hydrazino]carbonyl}phenyl)benzamide;

4-(Hexyloxy)-N-(4-{[2-(5-iodo-2-oxo-1,2-dihydro-3H-indol-3-ylidene)hydrazino]carbonyl}phenyl)benzamide;

4-Heptyl-N-(4-{[2-(5-iodo-2-oxo-1,2-dihydro-3H-indol-3-ylidene)hydrazino]carbonyl}phenyl)benzamide;

2-{2-Nitro-4,5-dimethoxyphenyl}-N′-[5-iodo-2-oxo-1,2-dihydro-3H-indol-3-yliden)acetohydrazide;

N′-(5-Iodo-2-oxo-1,2-dihydro-3H-indol-3-ylidene)-1-(3-pyridinylmethyl)-4-piperidinecarbohydrazide;

2-Amino-5-nitro-N′-(5-iodo-2-oxo-1,2-dihydro-3H-indol-3-ylidene)benzohydrazide;

2-[5-(3-Nitrophenyl)-2H-tetrazo1-2-yl]-N′-(5-iodo-2-oxo 1,2-dihydro-3H-indol-3-ylidene)acetohydrazide;

N′-(5-Iodo-2-oxo-1,2-dihydro-3H-indol-3-ylidene)-2-[5-( 1-pyrrolidinyl)-2H-tetrazol-2-yl]acetohydrazide;

N′-(5-Iodo-2-oxo-1,2-dihydro-3H-indol-3-ylidene)-2-[5-(4-morpholinyl)-2H-tetrazol-2-yl]acetohydrazide;

4-{2-[2-(5-Iodo-2-oxo-1,2-dihydro-3H-indol-3-ylidene)hydrazino]-2-oxoethoxy}benzoic acid;

4-{[2-(5-Iodo-2-oxo-1,2-dihydro-3H-indol-3-ylidene)hydrazino]carbonyl}-N-phenylbenzamide;

4-Cyano-N-(3-{[2-(5-iodo-2-oxo-1,2-dihydro-3H-indol-3-ylidene) hydrazino]carbonyl}phenyl)benzamide;

N′-[5-Iodo-2-oxo-1,2-dihydro-3H-indol-3-ylidene]-4-[4-(4-morpholinylmethyl) phenoxy]benzohydrazide;

N-(4-{[2-(5-Iodo-2-oxo-1,2-dihydro-3H-indol-3-ylidene)hydrazino]carbonyl}phenyl) benzamide;

4-(Benzyloxy)-N′-(5-iodo-2-oxo-1,2-dihydro-3H-indol-3-ylidene)benzohydrazide;

N-(3-{[2-(5-Iodo-2-oxo-1,2-dihydro-3H-indol-3-ylidene)hydrazino]carbonyl}phenyl)-3-phenyipropanamide;

4-{[2-(5-Iodo-2-oxo-1,2-dihydro-3H-indol-3-ylidene)hydrazino]carbonyl}-N-{3-[(trifluoromethyl)sulfonyl]phenyl}benzamide;

4-Chloro-N-(4-{[2-(5-iodo-2-oxo-1,2-dihydro-3H-indol-3-ylidene)hydrazino]-carbonyl }benzyl)benzamide;

Methyl 4-{3-[2-(5-iodo-2-oxo-1,2-dihydro-3H-indol-3-ylidene)hydrazino]-3-oxopropyl }benzoate;

2-[(2-Chlorophenoxy)methyl]-N′-(5-iodo-2-oxo-1,2-dihydro-3H-indol-3-ylidene)-1,3-thiazole-4-carbohydrazide;

N′-(5-Iodo-2-oxo-1,2-dihydro-3H-indol-3-ylidene)-2-(2-phenyl[1,3]thiazolo[3 ,2-b][1,2,4]triazol-6-yl)acetohydrazide;

4-{[3-Chloro-5-(trifluoromethyl)-2-pyridinyl]amino}-N′-[5-iodo-2-oxo-1,2-dihydro-3H-indol-3-ylidene]butanohydrazide;

2-{[3-Chloro-5-(trifluoromethyl)-2-pyridinyl]amino}-N′-(5-iodo-2-oxo-1,2-dihydro-3H-indol-3-ylidene)acetohydrazide;

1-Benzoyl-N′-(5-iodo-2-oxo-1,2-dihydro-3H-indol-3-ylidene)-4-piperidinecarbohydrazide;

N-(4-{[2-(5-Iodo-2-oxo-1,2-dihydro-3H-indol-3- ylidene) hydrazino]carbonyl}phenyl)-2-phenoxyacetamide;

N-(4-{[2-(5-Iodo-2-oxo-1,2-dihydro-3H-indol-3- ylidene)hydrazino]carbonyl}phenyl)-nicotinamide;

3-Nitro-N-(4-{[2-(5-iodo-2-oxo-1,2-dihydro-3H-indol-3-ylidene) hydrazino]carbonyl}-benzyl)benzamide;

N-(4-{[2-(5-Iodo-2-oxo-1,2-dihydro-3H-indol-3-ylidene)hydrazino]carbonyl}-phenyl)[1,1′-biphenyl]-4-carboxamide;

Methyl-3-{2-[2-(5-iodo-2-oxo-1,2-dihydro-3H-indol-3-ylidene)hydrazino]-2-oxoethoxy }benzoate;

Methyl-4-{[[2-(5-iodo-2-oxo-1,2-dihydro-3H-indol-3-ylidene)hydrazino](oxo)acetyl]-amino }benzoate;

3-(1,3-Benzodioxol-5-yl)-N-(4-{[2-(5-iodo-2-oxo-1,2-dihydro-3H-indol-3-ylidene)-hydrazine ]carbonyl}phenyl)propanamide;

4-[(4-{[2-(5-Iodo-2-oxo-1,2-dihydro-3H-indol-3-ylidene) hydrazino]carbonyl}benzoyl)-amino]benzoic acid;

3-(3,4-Dihydroxyphenyl)-N-(4-{[2-(5-iodo-2-oxo-1,2-dihydro-3H-indol-3-ylidene) hydrazino]carbonyl}phenyl)propanamide;

3-(3-Hydroxyphenyl)-N-(4-{[2-(5-iodo-2-oxo-1,2-dihydro-3H-indol-3-ylidene) hydrazino]-carbonyl}phenyl)propanamide;

N′-(5-Iodo-2-oxo-1,2-dihydro-3H-indol-3-ylidene)-6-methoxy-5-nitronicotinohydrazide;

3-{[2-(5-Iodo-2-oxo-1,2-dihydro-3H-indol-3-ylidene)hydrazino]sulfonyl}benzoic acid;

2-Hydroxy-5-{[2-(5-iodo-2-oxo-1,2-dihydro-3H-indol-3-ylidene) hydrazino]sulfonyl}-benzoic acid;

N′-(5-Iodo-2-oxo-1,2-dihydro-3H-indol-3-ylidene)-5-(2-pyridinyl)-2-thiophenesulfono-hydrazide;

4-Chloro-N′-(5-iodo-2-oxo-1,2-dihydro-3H-indol-3-ylidene)-3-nitrobenzenesulfono-hydrazide;

Methyl-{3-[(4-hydroxybenzoyl)hydrazono]-5-iodo-2-oxo-2,3-dihydro-1H-indol-1-yl }acetate;

N-Dodecyl-3-[(4-hydroxybenzoyl)hydrazono]-5-iodo-2-oxo-2,3-dihydro-1H-indole-1-carboxamide;

Methyl-(3-{[4-(hexanoylamino)benzoyl]hydrazono}-5-iodo-2-oxo-2,3-dihydro-1H-indol-1-yl)acetate;

(3-{[4-(hexanoylamino)benzoyl]hydrazono}-5-iodo-2-oxo-2,3-dihydro-1H-indol-1-yl) acetic acid;

(3-{[4-(hexanoylamino)benzoyl]hydrazono}-5-iodo-2-oxo-2,3-dihydro-1H-indol-1-yl) acetic acid, tromethanine (2-amino-2-hydroxymethyl-1,3-propanediol) salt;

(3-{[4-(hexanoylamino)benzoyl]hydrazono}-5-iodo-2-oxo-2,3-dihydro-1H-indol-1-yl) acetic acid, N-methyl-D-glucamine (1-deoxy-1-(methylamino)glucitol) salt;

2-(4-cyanophenoxy)-N′-(5-iodo-2-oxo-1,2-dihydro-3H-indol-3-ylidene) acetohydrazide;

4-({2-[2-(5-iodo-2-oxo-1,2-dihydro-3H-indol-3-ylidene)hydrazino]-2-oxoethyl}thio)-3-nitrobenzenesulfonamide;

N-(4-{[2-(5-iodo-2-oxo-1,2-dihydro-3H-indol-3-ylidene)hydrazino]carbonyl}phenyl)-N-methyl-3-phenyipropanamide;

methyl-{3-[(4-{[3-(1,3-benzodioxol-5-yl)propanoyl]amino}benzoyl)hydrazono]-5-iodo-2-oxo-2,3-dihydro-1H-indol-1-yl}acetate;

methyl-4-[(4-{[2-(5-iodo-2-oxo-1,2-dihydro-3H-indol-3-ylidene)hydrazino]carbonyl}-phenyl)amino]-4-oxobutanoate;

3-(1,3-benzodioxol-5-yl)-N-(4-{[2-(5-bromo-2-oxo-1,2-dihydro-3H-indol-3-ylidene)-hydrazine ]carbonyl}phenyl)propanamide;

{3-[(4-{[3-(1,3-benzodioxol-5-yl)propanoyl]amino}benzoyl)hydrazono]-5-iodo-2-oxo-2,3-dihydro-1H-indol-1-yl}acetic acid;

{3-[(4-{[3-(1,3-benzodioxol-5-yl)propanoyl]amino}benzoyl)hydrazono]-5-iodo-2-oxo-2,3-dihydro-1H-indol-1-yl}acetic acid, N-methyl-D-glucamine (1-deoxy-1-(methylamino) glucitol)salt;

methyl-6-[(4-{[2-(5-iodo-2-oxo-1,2-dihydro-3H-indol-3-ylidene)hydrazino]carbonyl}-phenyl)amino]-6-oxohexanoate;

methyl-4-{[(4-{[2-(5-iodo-2-oxo-1,2-dihydro-3H-indol-3-ylidene)hydrazino]carbonyl}-phenyl)amino]carbonyl}benzoate;

methyl-8-[(4-{[2-(5-iodo-2-oxo-1,2-dihydro-3H-indol-3-ylidene) hydrazino]carbonyl}-phenyl)amino]-8-oxooctanoate;

methyl-5-[(4-{[2-(5-iodo-2-oxo-1,2-dihydro-3H-indol-3-ylidene) hydrazino]carbonyl}-phenyl)amino]-5-oxopentanoate;

8-[(4-{[2-(5-iodo-2-oxo-1,2-dihydro-3H-indol-3-ylidene) hydrazino]carbonyl}phenyl)-amino]-8-oxooctanoic acid;

8-[(4-{[2-(5-iodo-2-oxo-1,2-dihydro-3H-indol-3-ylidene)hydrazino]carbonyl}phenyl)-amino]-8-oxooctanoic acid, N-methyl-D-glucamine (1-deoxy-1-(methylamino)glucitol) salt;

6-[(4-{[2-(5-iodo-2-oxo-1,2-dihydro-3H-indol-3-ylidene)hydrazino]carbonyl}phenyl)-amino]-6-oxohexanoic acid;

6-[(4-{[2-(5-iodo-2-oxo-1,2-dihydro-3H-indol-3-ylidene) hydrazino]carbonyl}phenyl)-amino]-6-oxohexanoic acid, N-methyl-D-glucamine (1- deoxy-1-(methylamino)glucitol) salt;

4-[(4-{[2-(5-iodo-2-oxo-1,2-dihydro-3H-indol-3-ylidene)hydrazino]carbonyl}phenyl)-amino]-4oxobutanoic acid;

4-{[(4-{[2-(5-iodo-2-oxo-1,2-dihydro-3H-indol-3-ylidene)hydrazine]carbonyl}benzyl)-amino]carbonyl}benzoic acid, N-methyl-D-glucamine (1-deoxy-1-(methylamino)-glucitol) salt;

5-[(4-{[(2-(5-iodo-2-oxo-1,2-dihydro-3H-indol-3-ylidene)hydrazino]carbonyl}phenyl)-amino]-5-oxopentanoic acid;

5-[(4-{[(2-(5-iodo-2-oxo-1,2-dihydro-3H-indol-3-ylidene) hydrazino]carbonyl}phenyl)-amino]-5-oxopentanoic acid, N-methyl-D-glucamine (1-deoxy-1-(methylamino)glucitol) salt;

4-{[(4-{[2-(5-iodo-2-oxo-1,2-dihydro-3H-indol-3-ylidene)hydrazino]carbonyl}phenyl)-amino]carbonyl}benzoic acid;

4-{[(4-{[2-(5-iodo-2-oxo-1,2-dihydro-3H-indol-3-ylidene) hydrazino]carbonyl}phenyl)-amino]carbonyl}benzoic acid, N-methyl-D-giucamine (1-deoxy-1-(methylamino)-glucitol) salt;

methyl-4-{[(4-{[2-(5-iodo-2-oxo-1,2-dihydro-3H-indol-3-ylidene) hydrazino]carbonyl}-benzyl)amino]carbonyl}benzoate;

4-{[(4-{[2-(5-iodo-2-oxo-1,2-dihydro-3H-indol-3-ylidene) hydrazino]carbonyl}benzyl)-amino]carbonyl}benzoic acid;

4-{[(4-{[2-(5-iodo-2-oxo-1,2-dihydro-3H-indol-3-ylidene)hydrazine]carbonyl}benzyl)-amino]carbonyl}benzoic acid, N-methyl-D-glucamine (1-deoxy-1-(methylamino)-glucitol) salt;

benzyl-(2S)-2-(4-{[2-(5-iodo-2-oxo-1,2-dihydro-3H-indol-3-ylidene)hydrazino]-carbonyl}phenoxy)-3-phenylpropanoate;

(2S)-2-(4-{[2-(5-iodo-2-oxo-1,2-dihydro-3H-indol-3-ylidene)hydrazino]carbonyl}-phenoxy)-3-phenyipropanoic acid;

(2S)-2-(4-{[2-(5-iodo-2-oxo-1,2-dihydro-3H-indol-3-ylidene)hydrazino]carbonyl}-phenoxy)-3-phenyipropanoic acid, N-methyl-D-glucamine (1-deoxy-1-(methylamino) glucitol) salt;

methyl-4-{3-[(4-{[3-(1,3-benzodioxol-5-yl)propanoyl]amino }benzoyl)hydrazonoll-5-iodo-2-oxo-2,3-dihydro-1H-indol-1-yl}butanoate;

4-{3-[(4-{[3-(1,3-benzodioxol-5-yl)propanoyl]amino }benzoyl)hydrazono]-5-odo-2-oxo-2,3-dihydro-1H-indol-1-yl}butanoic acid;

4-{3-[(4-{[3-(1,3-benzodioxol-5-yl)propanoyl]amino }benzoyl)hydrazono]-5-iodo-2-oxo-2,3-dihydro-1H-indol-1-yl}butanoic acid, N-methyl-D-glucamine (1-deoxy-1-(methylamino)glucitol) salt;

methyl-3-(4-{[(4-{[2-(5-iodo-2-oxo-1,2-dihydro-3H-indol-3-ylidene)hydrazino]-carbonyl}phenyl)amino]sulfonyl}phenyl)propanoate;

3-(4-{[(4-{[2-(5-iodo-2-oxo-1,2-dihydro-3H-indol-3-ylidene)hydrazino]carbonyl}-phenyl)amino]sulfonyl}phenyl) propanoic acid; and

3-(4-{[(4-{[2-(5-iodo-2-oxo-1,2-dihydro-3H-indol-3-ylidene)hydrazino]carbonyl }-phenyl)amino]sulfonyl}phenyl) propanoic acid, N-methyl-D-glucamine (1-deoxy-1-(methylamino) glucitol) salt.

5. An oxindole hydrazide selected from the group consisting of:

4-Nitro-N′-(5-bromo-2-oxo-1,2-dihydro-3H-indol-3-ylidene)benzohydrazide;

Methyl-4-{2-[2-(5-bromo-2-oxo-1,2-dihydro-3H-indol-3-ylidene)hydrazino]-2-oxoethoxy}benzoate;

4-Methoxy-N′-(5-bromo-2-oxo-1,2-dihydro-3H-indol-3-ylidene)benzohydrazide;

N-(4-{[2-(5-Bromo-2-oxo-1,2-dihydro-3H-indol-3-ylidene)hydrazino]carbonyl }phenyl)-3-phenylpropanamide;

N′-(5-Bromo-2-oxo-1,2-dihydro-3H-indol-3-ylidene)-4-{3-[2-(5-bromo-2-oxo-1,2-dihydro-3H-indol-3-ylidene)hydrazino]-3-oxopropyl }benzohydrazide;

N-(4-{[2-(5-Bromo-2-oxo-1,2-dihydro-3H-indol-3-ylidene)hydrazino]carbonyl }-phenyl)-2-phenoxyacetamide;

N-(4-{[2-(5-Bromo-2-oxo-1,2-dihydro-3H-indol-3-ylidene)hydrazino]carbonyl}-benzyl)-3-nitrobenzamide;

Methyl 3-{2-[2-(5-bromo-2-oxo-1,2-dihydro-3H-indol-3-ylidene)hydrazino]-2-oxoethoxy}benzoate;

N′-(5-Bromo-2-oxo-1,2-dihydro-3H-indol-3-ylidene)-2-[4-( 1H-tetrazol-5-yl)phenoxy]acetohydrazide; and

N′-(5-Bromo-2-oxo-1,2-dihydro-3H-indol-3-ylidene)-4-(1H-tetrazol-5-yl)benzohydrazide.

6. An oxindole hydrazide of formula (II):

wherein A is O or a bond;

wherein B is selected from the group consisting of phenyl, biphenyl, benzo (1,2,5) oxadiazolyl, furyl, thiadiazolyl, thienyl, thiazolyl, indolyl, piperidinyl, tetrazolyl, 1,2,3-triazolyl, 1,2,4-triazolyl and pyridyl;

R 8 is selected in the group consisting of H, halogen, cyano, (C 1 -C 6 )alkyl, aryl, heteroaryl, —SO—R 9 , —SO 2 , —R 9 , (C 1 -C 6 )alkyl-SO 2 —R 9 , —NO 2 , —N(R 9 ) 2 , (C 1 -C 6 )-alkyl-O—R 9 , —SR 9 , —SO 2 —R 9 , —(C═O)O—R 9 , —(C═O)—R 9 , —(C═O)N(R 9 ) 2 , —(C═O)NH—R 2 , —(C═O)NR 9 —N(R 9 ) 2 , —NR 9 —(C═O)—N(R 9 ) 2 , —NR 9 —(SO 2 —R 9 ), —NH—(C═O)—R 9 , (C 1 -C 6 )-alkyl-NH—(C═O)-R 9 , —NR 9 —(C═O)—R 9

wherein R 9 is selected from the group consisting of H, C 3 -C 8 cycloalkyl, 3-8 membered heterocycloalkyl which may contain 1-2 further heteroatoms selected from O, N or S, (C 1 -C 6 )-alkyl-heterocycloalkyl wherein said heterocycloalkyl may contain 1-2 further heteroatoms selected from O, N or S, aryl, (C 1 -C 6 )-alkyl-aryl, (C 1 -C 6 )-alkoxy-aryl, heteroaryl, (C 1 -C 6 )-alkyl-heteroaryl or (C 1 -C 6 )-alkoxy-heteroaryl, (C 1 -C 6 )-alkyl, (C 1 -C 6 )-alkyl-COOR 10 wherein R 10 is H or (C 1 -C 6 )alkyl or —NH 2

m′ is 0 or 1;

p is an integer from 1 to 3;

with the proviso that the following compounds are excluded:

7. A pharmaceutical composition comprising at least one oxindole hydrazide according to claim 1 , and a pharmaceutically acceptable carrier, diluent or excipient thereof.

8. A method of preparing an oxindole of formula (I) according to claim 1 ,

which comprises:

reacting A and B as follows:

9. A method according to claim 8 , wherein compound B is prepared by a process, which comprises:

reacting (C) with PG-NH—NH—R 3 as follows:

wherein R is C 1 -C 6 alkyl group and PG, R, A, B, R 8 m, n and p are as above defined.

Assignments (3)
CHANGE OF NAME Recorded Dec 3, 2009
From: LABORATOIRES SERONO SA
To: MERCK SERONO SA
Reel/Frame 023599/0944 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 11, 2007
From: APPLIED RESEARCH SYSTEMS ARS HOLDING N.V.
To: LABORATOIRES SERONO SA
Reel/Frame 019966/0026 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 5, 2004
From: BOMBRUN, AGNES; GERBER, PATRICK; CHURCH, DENIS
To: APPLIED RESEARCH SYSTEMS ARS HOLDING N.V.
Reel/Frame 015856/0717 →